請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/70269
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 林靖愉 | |
dc.contributor.author | Yi-Ru Chen | en |
dc.contributor.author | 陳怡儒 | zh_TW |
dc.date.accessioned | 2021-06-17T04:25:02Z | - |
dc.date.available | 2023-09-04 | |
dc.date.copyright | 2018-09-04 | |
dc.date.issued | 2018 | |
dc.date.submitted | 2018-08-15 | |
dc.identifier.citation | 1. Osmond MJ, Mccall MJ: Zinc oxide nanoparticles in modern sunscreens: an analysis of potential exposure and hazard. Nanotoxicology 2010, 4(1):15-41.
2. Gordon T, Fine JM: Metal fume fever. Occupational medicine (Philadelphia, Pa) 1993, 8(3):504-517. 3. Fine JM, Gordon T, Chen LC, Kinney P, Falcone G, Beckett WS: Metal fume fever: characterization of clinical and plasma IL-6 responses in controlled human exposures to zinc oxide fume at and below the threshold limit value. Journal of occupational and environmental medicine 1997, 39(8):722-726. 4. Jacobsen NR, Stoeger T, van den Brule S, Saber AT, Beyerle A, Vietti G, Mortensen A, Szarek J, Budtz HC, Kermanizadeh A et al: Acute and subacute pulmonary toxicity and mortality in mice after intratracheal instillation of ZnO nanoparticles in three laboratories. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 2015, 85:84-95. 5. Morimoto Y, Izumi H, Yoshiura Y, Tomonaga T, Oyabu T, Myojo T, Kawai K, Yatera K, Shimada M, Kubo M: Evaluation of pulmonary toxicity of zinc oxide nanoparticles following inhalation and intratracheal instillation. International journal of molecular sciences 2016, 17(8):1241. 6. Ho M, Wu K-Y, Chein H-M, Chen L-C, Cheng T-J: Pulmonary toxicity of inhaled nanoscale and fine zinc oxide particles: mass and surface area as an exposure metric. Inhalation toxicology 2011, 23(14):947-956. 7. Chuang H-C, Juan H-T, Chang C-N, Yan Y-H, Yuan T-H, Wang J-S, Chen H-C, Hwang Y-H, Lee C-H, Cheng T-J: Cardiopulmonary toxicity of pulmonary exposure to occupationally relevant zinc oxide nanoparticles. Nanotoxicology 2014, 8(6):593-604. 8. Johnson BM, Fraietta JA, Gracias DT, Hope JL, Stairiker CJ, Patel PR, Mueller YM, McHugh MD, Jablonowski LJ, Wheatley MA et al: Acute exposure to ZnO nanoparticles induces autophagic immune cell death. Nanotoxicology 2015, 9(6):737-748. 9. Khanna P, Ong C, Bay BH, Baeg GH: Nanotoxicity: an interplay of oxidative stress, inflammation and cell death. Nanomaterials 2015, 5(3):1163-1180. 10. Lee S-H, Wang T-Y, Hong J-H, Cheng T-J, Lin C-Y: NMR-based metabolomics to determine acute inhalation effects of nano- and fine-sized ZnO particles in the rat lung. Nanotoxicology 2016, 10(7):924-934. 11. Lee S-H, Tang C-H, Lin W-Y, Chen K-H, Liang H-J, Cheng T-J, Lin C-Y: LC-MS-based lipidomics to examine acute rat pulmonary responses after nano-and fine-sized ZnO particle inhalation exposure. Nanotoxicology 2018:1-14. 12. Fahy E, Subramaniam S, Brown HA, Glass CK, Merrill AH, Murphy RC, Raetz CR, Russell DW, Seyama Y, Shaw W: A comprehensive classification system for lipids. Journal of lipid research 2005, 46(5):839-862. 13. Liebisch G, Vizcaíno JA, Köfeler H, Trötzmüller M, Griffiths WJ, Schmitz G, Spener F, Wakelam MJ: Shorthand notation for lipid structures derived from mass spectrometry. Journal of lipid research 2013:jlr. M033506. 14. Shevchenko A, Simons K: Lipidomics: coming to grips with lipid diversity. Nature reviews Molecular cell biology 2010, 11(8):593. 15. Zhao Y-Y, Miao H, Cheng X-L, Wei F: Lipidomics: Novel insight into the biochemical mechanism of lipid metabolism and dysregulation-associated disease. Chemico-biological interactions 2015, 240:220-238. 16. Zhao Y-Y, Wu S-P, Liu S, Zhang Y, Lin R-C: Ultra-performance liquid chromatography–mass spectrometry as a sensitive and powerful technology in lipidomic applications. Chemico-biological interactions 2014, 220:181-192. 17. Wenk MR: The emerging field of lipidomics. Nature reviews Drug discovery 2005, 4(7):594. 18. Griffiths WJ, Wang Y: Mass spectrometry: from proteomics to metabolomics and lipidomics. Chemical Society Reviews 2009, 38(7):1882-1896. 19. Cajka T, Fiehn O: Comprehensive analysis of lipids in biological systems by liquid chromatography-mass spectrometry. TrAC Trends in Analytical Chemistry 2014, 61:192-206. 20. Tang C-H, Tsao P-N, Lin C-Y, Fang L-S, Lee S-H, Wang W-H: Phosphorylcholine-containing lipid molecular species profiling in biological tissue using a fast HPLC/QqQ-MS method. Analytical and bioanalytical chemistry 2012, 404(10):2949-2961. 21. Cajka T, Fiehn O: Toward merging untargeted and targeted methods in mass spectrometry-based metabolomics and lipidomics. Analytical chemistry 2015, 88(1):524-545. 22. Kang YP, Lee WJ, Hong JY, Lee SB, Park JH, Kim D, Park S, Park C-S, Park S-W, Kwon SW: Novel approach for analysis of bronchoalveolar lavage fluid (BALF) using HPLC-QTOF-MS-based lipidomics: lipid levels in asthmatics and corticosteroid-treated asthmatic patients. Journal of proteome research 2014, 13(9):3919-3929. 23. Sandra K, Pereira Ados S, Vanhoenacker G, David F, Sandra P: Comprehensive blood plasma lipidomics by liquid chromatography/quadrupole time-of-flight mass spectrometry. Journal of chromatography A 2010, 1217(25):4087-4099. 24. t’Kindt R, Telenga ED, Jorge L, Van Oosterhout AJ, Sandra P, Ten Hacken NH, Sandra K: Profiling over 1500 lipids in induced lung sputum and the implications in studying lung diseases. Analytical chemistry 2015, 87(9):4957-4964. 25. Triebl A, Trötzmüller M, Hartler J, Stojakovic T, Köfeler HC: Lipidomics by ultrahigh performance liquid chromatography-high resolution mass spectrometry and its application to complex biological samples. Journal of Chromatography B 2017, 1053:72-80. 26. Godzien J, Ciborowski M, Martínez-Alcázar MP, Samczuk P, Kretowski A, Barbas C: Rapid and reliable identification of phospholipids for untargeted Metabolomics with LC–ESI–QTOF–MS/MS. Journal of proteome research 2015, 14(8):3204-3216. 27. Leuthold P, Schaeffeler E, Winter S, Büttner F, Hofmann U, Mürdter TE, Rausch S, Sonntag D, Wahrheit J, Fend F: Comprehensive metabolomic and lipidomic profiling of human kidney tissue: a platform comparison. Journal of proteome research 2017, 16(2):933-944. 28. Ishikawa M, Saito K, Yamada H, Nakatsu N, Maekawa K, Saito Y: Plasma lipid profiling of different types of hepatic fibrosis induced by carbon tetrachloride and lomustine in rats. Lipids in health and disease 2016, 15(1):74. 29. Yan F, Wen Z, Wang R, Luo W, Du Y, Wang W, Chen X: Identification of the lipid biomarkers from plasma in idiopathic pulmonary fibrosis by Lipidomics. BMC pulmonary medicine 2017, 17(1):174. 30. Folch J, Lees M, Sloane Stanley G: A simple method for the isolation and purification of total lipids from animal tissues. J biol Chem 1957, 226(1):497-509. 31. Xie Y, Ma H, Wei F, Lyu X, Wu Z, Wu B, Xu S: Importance of quality control in lipidomics profiling based on mass spectrometry. Oil Crop Science 2017, 2(4):217. 32. Broadhurst D, Goodacre R, Reinke SN, Kuligowski J, Wilson ID, Lewis MR, Dunn WB: Guidelines and considerations for the use of system suitability and quality control samples in mass spectrometry assays applied in untargeted clinical metabolomic studies. Metabolomics 2018, 14(6):72. 33. Worley B, Powers R: Multivariate analysis in metabolomics. Current Metabolomics 2013, 1(1):92-107. 34. ZHENG S, ZHANG Y, Guangyang L, Jun L, Zhongxiao L, Xiaomin X, Lingyun L, Donghui X: Glycerolipid Profiling of Yellow Sarson Seeds Using Ultra High Performance Liquid Chromatography Coupled to Triple Time-of-Flight Mass Spectrometry. Horticultural Plant Journal 2017, 3(4):141-150. 35. Feingold KR, Grunfeld C: Introduction to lipids and lipoproteins. 2015. 36. Hishikawa D, Hashidate T, Shimizu T, Shindou H: Diversity and function of membrane glycerophospholipids generated by the remodeling pathway in mammalian cells. Journal of lipid research 2014, 55(5):799-807. 37. Gibellini F, Smith TK: The Kennedy pathway—de novo synthesis of phosphatidylethanolamine and phosphatidylcholine. IUBMB life 2010, 62(6):414-428. 38. Yen C-LE, Stone SJ, Koliwad S, Harris C, Farese RV: Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis. Journal of lipid research 2008, 49(11):2283-2301. 39. Fernández-Murray JP, McMaster CR: Glycerophosphocholine catabolism as a new route for choline formation for phosphatidylcholine synthesis by the Kennedy pathway. Journal of Biological Chemistry 2005, 280(46):38290-38296. 40. Gubern A, Barceló-Torns M, Casas J, Barneda D, Masgrau R, Picatoste F, Balsinde J, Balboa MA, Claro E: Lipid droplet biogenesis induced by stress involves triacylglycerol synthesis that depends on group VIA phospholipase A2. Journal of Biological Chemistry 2009, 284(9):5697-5708. 41. Guerrera IC, Astarita G, Jais J-P, Sands D, Nowakowska A, Colas J, Sermet-Gaudelus I, Schuerenberg M, Piomelli D, Edelman A: A novel lipidomic strategy reveals plasma phospholipid signatures associated with respiratory disease severity in cystic fibrosis patients. PLoS One 2009, 4(11):e7735. 42. Begum K, Begum M, Sarker Z, Dewan M, Siddique M: Lipid profile status of chronic obstructive pulmonary disease in hospitalized patients. Bangladesh Journal of Medical Biochemistry 2013, 3(2):42-45. 43. Yagupsky P, Shahak E, Tal A, Bearman JE, Zulli I, Shany S: Lipoprotein profile of children with asthma receiving long-term theophylline therapy: a preliminary study. The Journal of pediatrics 1992, 120(5):802-805. 44. Romero F, Shah D, Duong M, Stafstrom W, Hoek JB, Kallen CB, Lang CH, Summer R: Chronic alcohol ingestion in rats alters lung metabolism, promotes lipid accumulation, and impairs alveolar macrophage functions. American journal of respiratory cell and molecular biology 2014, 51(6):840-849. 45. Zhao Y: Zinc oxide nanoparticle caused plasma metabolomic perturbations correlate with hepatic steatosis. Frontiers in Pharmacology 2018, 9:57. 46. Kotronen A, Seppänen‐Laakso T, Westerbacka J, Kiviluoto T, Arola J, Ruskeepää AL, Yki‐Järvinen H, Orešič M: Comparison of Lipid and Fatty Acid Composition of the Liver, Subcutaneous and Intra‐abdominal Adipose Tissue, and Serum. Obesity 2010, 18(5):937-944. 47. Ahmadian M, Duncan RE, Jaworski K, Sarkadi-Nagy E, Sook Sul H: Triacylglycerol metabolism in adipose tissue. Future lipidology 2007, 2(2):229-237. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/70269 | - |
dc.description.abstract | 脂質體學為代謝體學其中一個分支,其針對細胞、組織或生物液等樣本內之脂質進行全面性的分析,藉以了解外在環境或刺激對於生物體內脂質造成的影響。過去研究中,氧化鋅微粒的暴露被證實與人、實驗動物產生金屬煙燻熱及肺部發炎、肝臟傷害等不良健康效應有關。此外,本實驗室過去的研究也發現吸入氧化鋅微粒的大鼠,其肺部沖洗液和肺部組織中代謝物及脂質產生擾動。然而,有關於氧化鋅微粒造成系統性脂質改變的研究有限,本研究應用極致高效能液相層析搭配四極柱串聯飛行時間質譜儀,對於大鼠血漿中脂質進行非標的脂質體分析,藉以了解氧化鋅微粒暴露對於大鼠血漿中脂質產生的擾動。
多種類別脂質標準品用於分析方法的測試,包含甘油脂質、甘油磷脂質、鞘脂質等能在系統中有效偵測,且經由二級質譜圖確認。系統確認後,應用該系統分析呼吸暴露於250 nm氧化鋅微粒之七週大SD大鼠血漿與吸入過濾後乾淨空氣之控制組大鼠血漿,進行進一步的脂質分析。經圖譜處理後,血漿中脂質有超過1000筆特徵訊號被保留,80%之訊號其相對標準差小於20%,顯示該系統在分析上存在良好穩定性,能夠進行後續的統計分析及深入探討。 本研究發現大鼠血漿中脂質組成主要以甘油脂質及甘油磷脂質為主。在多變量及單變量統計結果中發現250 nm氧化鋅微粒暴露之暴露組和控制組之大鼠血漿脂質存在明顯差異,磷脂醯膽鹼及三酸甘油脂為最主要顯著改變之脂質類別。本研究發現的脂質改變可能與氧化鋅微粒暴露引發的肺部、肝臟相關傷害有關。 本研究成功利用極致高效能液相層析搭配四極柱串聯飛行時間質譜儀系統對大鼠血漿中的脂質成分進行了解,並進一步應用於探討氧化鋅微粒暴露對脂質產生的效應。將來該系統可應用於了解不同器官或生物液之脂質成分。此外,本研究的發現也為開發氧化鋅顆粒暴露的脂質生物標誌物篩選提供了進一步了解。 | zh_TW |
dc.description.abstract | Lipidomics, a subset of metabolomics, is the comprehensive measurement of the lipids in cells, tissues, biological fluids, and so on, in order to link lipid changes with gene modification or environment stress. ZnO exposure is linked to metal fume fever and pulmonary inflammation symptoms in the human and experiment animals. Besides, the perturbation of metabolites and lipids from bronchoalveolar lavage fluid and lung tissues of ZnO particles inhaled rats were observed in our recent studies. However, the knowledge of systemic lipids changes after ZnO particles exposure was limited.
The objectives of present study were utilized an untargeted lipidomic approach by ultra-high-performance liquid chromatography (UHPLC) combined with quadrupole-time of flight (Q-TOF) mass spectrometry (MS) and applied to investigate changes of lipidome from the plasma of rats inhaled ZnO particles. Several classes of lipid standards used to test the analytical method, including lysophospholipids, monoacylglycerols, phospholipids, sphingomyelins, ceramides, diacylglycerols, triacylglycerols were successfully detected in this system. Then, plasma lipids profiling on plasma samples from 7-week male SD rats treated with 250 nm ZnO particles by inhalation for 24 hours and the filtered control were analyzed by the UHPLC-QTOF/MS system. After data processing, more than 1000 features of the lipid in the plasma were retained, 80% signal showed the relative standard deviation was less than 20%, indicating the good stability in the system, providing the data which can be further investigated and discussion. In the plasma of male SD rat, glycerolipids and glycerolphospholipids were the most dominant lipid categories. Multivariate and univariate statistical analysis were used to examine the differences of lipidome from the ZnO particles exposure and control rats. In this study, glycerolphosphocholines and triacylglycerols represented the major significant changed lipid subclasses. These findings were possibly related to lung and liver injury induced by ZnO particles exposure. This study successfully utilized the UHPLC-QTOF/MS system to understand the lipid composition in the rat plasma and further applied it to examine the lipid effects of ZnO particle exposure. In the future, the system can be used to explore the lipid changes in different organs or biological fluids. The findings in the study also provide a better insight for developing the potential lipid biomarker for ZnO particles exposure. | en |
dc.description.provenance | Made available in DSpace on 2021-06-17T04:25:02Z (GMT). No. of bitstreams: 1 ntu-107-R05844010-1.pdf: 1264823 bytes, checksum: f77ade56e2c6c17266f15809914a3ccf (MD5) Previous issue date: 2018 | en |
dc.description.tableofcontents | 致謝 i
摘要 ii Abstract iii Content v List of Figures vii List of Tables ix Chapter 1. Introduction 1 1.1 Background 1 1.1.1 ZnO particles 1 1.1.2 Lipids 2 1.1.3 Lipidomics 4 1.2 Study aim 6 Chapter 2. Materials and methods 7 2.1 Experimental flow chart 7 2.2 Analytical method 8 2.2.1 Data acquisition for lipid standards 8 2.2.2 Data processing 10 2.3 Application on biological sample for lipid profiling 10 2.3.1 Animals 10 2.3.2 Exposure system of the ZnO particle 11 2.3.3 Sample preparation 11 2.3.4 Data acquisition for lipid profiling 12 2.3.5 Data processing 13 2.3.6 Statistical analysis 13 2.3.7 Lipid identification 14 Chapter 3. Results 16 3.1 Analytical method 16 3.2 Lipid profiling on the rat plasma 18 3.3 Multivariate analysis of the effects of 250nm ZnO particles exposure on rat plasma 19 3.4 Univariate analysis of the effects of 250nm ZnO particles exposure on rat plasma 20 Chapter 4. Discussion 22 4.1 Analytical method 22 4.2 Lipid profiling on the rat plasma 24 4.3 Effects of 250nm ZnO particles exposure on rat plasma 26 4.4 Strengths, limitations and future work 30 Chapter 5. Conclusion 32 References 33 Appendix 64 | |
dc.language.iso | en | |
dc.title | 應用極致高效能液相層析搭配四極柱串聯飛行時間質譜儀探討氧化鋅微粒暴露後大鼠血漿之脂質體改變 | zh_TW |
dc.title | Using UHPLC-QTOF/MS based lipidomics to study lipid effects of ZnO particle exposure on the rat plasma | en |
dc.type | Thesis | |
dc.date.schoolyear | 106-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 鄭尊仁,陳家揚,唐川禾 | |
dc.subject.keyword | 氧化鋅微粒,脂質體學,質譜儀,毒性,血漿, | zh_TW |
dc.subject.keyword | ZnO particles,Lipidomics,Q-TOF/MS,Toxicity,Plasma, | en |
dc.relation.page | 73 | |
dc.identifier.doi | 10.6342/NTU201803129 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2018-08-15 | |
dc.contributor.author-college | 公共衛生學院 | zh_TW |
dc.contributor.author-dept | 環境衛生研究所 | zh_TW |
顯示於系所單位: | 環境衛生研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-107-1.pdf 目前未授權公開取用 | 1.24 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。